HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behavior.
about
Genetic and molecular alterations in olfactory neuroblastoma - implications for pathogenesis, prognosis and treatmentLarge Cell Neuroendocrine Carcinoma of the Head and Neck: A Clinicopathologic Series of 10 Cases With an Emphasis on HPV Status.Role of human papillomavirus in oropharyngeal squamous cell carcinoma: A review.Use of p40 and p63 immunohistochemistry and human papillomavirus testing as ancillary tools for the recognition of head and neck sarcomatoid carcinoma and its distinction from benign and malignant mesenchymal processes.A retrospective investigation on canine papillomavirus 1 (CPV1) in oral oncogenesis reveals dogs are not a suitable animal model for high-risk HPV-induced oral cancer.Metastatic HPV-related head and neck squamous cell carcinoma to the lung and mediastinal lymph nodes in aspirated cytology material: A diagnostic pitfall.HPV-associated head and neck cancer: molecular and nano-scale markers for prognosis and therapeutic stratificationHPV-related squamous cell carcinoma variants in the head and neck.Human papillomavirus-associated small cell carcinoma/neuroendocrine carcinoma of the oropharynx: a report of two cases.Metastatic squamous cell carcinoma to the brain: an unrecognized pattern of distant spread in patients with HPV-related head and neck cancerHuman papillomavirus-16 associated adenocarcinoma NOS of base of tongue.Spindle cell carcinomas of the head and neck rarely harbor transcriptionally-active human papillomavirusHighly aggressive human papillomavirus-related oropharyngeal cancer: clinical, radiologic, and pathologic characteristics.Small cell neuroendocrine carcinoma of the oropharynx harbouring oncogenic HPV-infection.The expanding role of cytopathology in the diagnosis of HPV-related squamous cell carcinoma of the head and neck.Human papillomavirus-associated adenocarcinoma of the base of tongue: potentially actionable genetic changes.Histopathologic risk factors in oral and oropharyngeal squamous cell carcinoma variants: an update with special reference to HPV-related carcinomas.Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Oropharynx.HPV-related carcinomas of the head and neck: morphologic features, variants, and practical considerations for the surgical pathologist.p16 overexpression in high-grade neuroendocrine carcinomas of the head and neck: potential diagnostic pitfall with HPV-related carcinomas.[Epithelial neuroendocrine tumors of the upper respiratory tract: New entities, new perspectives].Biphenotypic human papillomavirus-associated head and neck squamous cell carcinoma: a report of two cases.Primary combined neuroendocrine and squamous cell carcinoma of the maxillary sinus: report of a case with immunohistochemical and molecular characterization.Morphologic diversity in human papillomavirus-related oropharyngeal squamous cell carcinoma: Catch Me If You Can!Survival Outcomes in Oropharyngeal Small-Cell Carcinoma Compared With Squamous Cell Carcinoma: A Population-Based Study.Human papillomavirus associated head and neck squamous cell carcinoma: Controversies and new concepts.Epstein-Barr Virus-Positive Large Cell Neuroendocrine Carcinoma of the Nasopharynx: Report of a Case with Complete Clinical and Radiological Response After Combined Chemoradiotherapy.[Neuroendocrine neoplasms of the head and neck].Human Papillomavirus-Related Neuroendocrine Carcinomas of the Head and Neck.Squamous and Neuroendocrine Specific Immunohistochemical Markers in Head and Neck Squamous Cell Carcinoma: A Tissue Microarray Study.A robust response to combination immune checkpoint inhibitor therapy in HPV-related small cell cancer: a case report.Tonsillar Small Cell Carcinoma: Potential Contribution of Human Papillomavirus.Prognosis of HPV-positive head and neck cancers: implication of smoking and immunosuppressionCurrent status of clinical testing for human papillomavirus in oropharyngeal squamous cell carcinoma
P2860
Q26743508-260769CC-EBDC-4C6A-866E-49D5BD7FDA17Q30277802-EBA947EB-D251-4D96-A9EB-243F6668DB1AQ33770030-F28C004B-21A8-49C1-AAD6-951FACE8998EQ35038162-61559841-12DF-4138-AF9A-7499DCCF6915Q35426521-0B02B5D6-1EB6-49C6-9197-DC06E843E22AQ35893459-1F0F8FAB-E74F-46CF-8745-7BCA8191BCA0Q35969807-0665D34F-5AEF-4D17-A308-595A26938A3FQ36088099-C948E2E0-F335-4A03-94D4-592E537D1B56Q36183897-517D09C7-72BD-4549-AAC3-EEA038C37E0FQ36778066-53331460-AFF5-453C-AF57-A781066949C6Q37083209-B928ED26-7353-4E11-8247-685637281E3BQ37083252-215C2A5B-7EB6-4E62-BA34-493668FE4400Q37106973-A8394361-1C73-4939-876B-4BF20812CFD7Q37631286-DA42830B-D074-4D65-98BF-245812463769Q38113193-EF37C125-3FB2-4132-BA91-56226C4261B7Q38164587-DA4DE6D5-96A8-4B1C-83A9-943003CEB99BQ38216311-DF9EE9E2-38BC-47A8-BA0A-042339F65A4DQ39155694-B884EB23-195B-4FBD-B14A-09A4ED834C80Q39247309-65A2B161-0742-4301-8759-D652EE6AA25EQ40620491-93329832-30AE-41CB-B3B6-49D21AE840ECQ41240433-01BA94CD-D636-42E6-815D-D4FD553E5767Q41464416-79446114-0FEB-4171-8667-825CC50E0399Q42011173-2D1292CE-75EB-4AB7-8351-B11672D7FCC4Q42059681-DE58F5A4-1DE6-4861-B39F-377F1A66BD3EQ45061119-99B6F9C6-1712-471B-8AA8-7B5C2663C91FQ47095041-C3B11C23-8FEF-46FC-858F-9125B5F8570DQ47557911-E4117219-6375-49FF-8970-BDC9C347B47AQ50128151-5C8BFC60-BE78-42BB-B90D-4532AF6FF439Q51732885-2B89DB6F-F250-4849-BC21-DECBEBBAC137Q54586794-F8184C03-EE21-44E1-972D-4F44E1804CD1Q55092262-CFC745AD-D76D-4665-841B-4EF139CAB786Q55522286-2EC899EE-2A6D-4444-80D9-6E840384EF84Q58127069-9CE63D8C-25C1-4382-949E-D966ED4C2883Q58721847-47E5FC3F-8243-40D3-BA36-7BF6FFEB7633
P2860
HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behavior.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
HPV-associated neuroendocrine ...... aggressive clinical behavior.
@en
HPV-associated neuroendocrine ...... aggressive clinical behavior.
@nl
type
label
HPV-associated neuroendocrine ...... aggressive clinical behavior.
@en
HPV-associated neuroendocrine ...... aggressive clinical behavior.
@nl
prefLabel
HPV-associated neuroendocrine ...... aggressive clinical behavior.
@en
HPV-associated neuroendocrine ...... aggressive clinical behavior.
@nl
P2093
P1476
HPV-associated neuroendocrine ...... aggressive clinical behavior.
@en
P2093
Jeffrey F Krane
Stefan Kraft
William C Faquin
P304
P356
10.1097/PAS.0B013E31823F2F17
P407
P577
2012-03-01T00:00:00Z